a public good project by the
Synthesis
Company
of California

© 2026

Sven Waßmann | doi.page

0 works0 citations0 h-index

Sven Waßmann

Biomax Informatics (Germany)(DE)Lungenheilkunde München-Pasing(DE)Saarland University(DE)

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Renin-Angiotensin System Studies, Antiplatelet Therapy and Cardiovascular Diseases, Atherosclerosis and Cardiovascular Diseases, Blood Pressure and Hypertension Studies

Most-Cited Works

→ 2018 ESC/ESH Guidelines for the management of arterial hypertension(2018)10,255 cited
→ 2014 ESC/EACTS Guidelines on myocardial revascularization(2014)4,205 cited
→ 2023 ESC Guidelines for the management of acute coronary syndromes(2023)4,018 cited
→ Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis(2003)847 cited
→ Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo(2002)591 cited
→ Modulation of Antioxidant Enzyme Expression and Function by Estrogen(2003)474 cited

→ Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 Receptor(2003)

461 cited

→ HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen Species(2001)458 cited

→ Modulation of Oxidant and Antioxidant Enzyme Expression and Function in Vascular Cells(2004)350 cited

→ Inhibition of Geranylgeranylation Reduces Angiotensin II-Mediated Free Radical Production in Vascular Smooth Muscle Cells: Involvement of Angiotensin AT1 Receptor Expression and Rac1 GTPase(2001)340 cited